4,421,053 Shares and Pre-Funded Warrants to Purchase 257,310 Shares Fate Therapeutics, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • January 8th, 2021 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 8th, 2021 Company Industry JurisdictionThe foregoing will not apply to the registration of the offer and sale of the Shares, and the sale of the Shares to the underwriters, in each case as contemplated by the Underwriting Agreement. In addition, the foregoing restrictions shall not apply: